These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7293796)

  • 1. Effects of apomorphine and haloperidol on plasma cortisol levels in conscious dogs.
    Uvnäs-Wallensten K; Goiny M; Oriowo MA; Cekan S
    Acta Physiol Scand; 1981 Jul; 112(3):253-6. PubMed ID: 7293796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of apomorphine on peripheral venous gastrin and insulin levels in conscious dogs.
    Uvnäs-Wallensten K; Goiny M
    Acta Physiol Scand; 1981 Jun; 112(2):155-60. PubMed ID: 7032213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopaminergic drugs on plasma levels of steroid hormones in conscious dogs.
    Goiny M; Cekan S; Uvnäs-Moberg K
    Life Sci; 1986 Jun; 38(25):2293-300. PubMed ID: 3724358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromocriptine and apomorphine stimulation of cortisol secretion in conscious dogs; evidence for a stimulatory site located outside the blood brain barrier.
    Goiny M; Uvnäs-Moberg K; Cekan S
    Psychopharmacology (Berl); 1986; 89(1):108-12. PubMed ID: 3090584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in plasma ACTH after dopaminergic stimulation in rats.
    Jezová D; Jurcovicová J; Vigas M; Murgas K; Labrie F
    Psychopharmacology (Berl); 1985; 85(2):201-3. PubMed ID: 2989967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
    Nowak JZ; Arbilla S; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of the hypotensive effect of apomorphine].
    Montastruc JL; Guiol C
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1176-80. PubMed ID: 6441536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs.
    Damase-Michel C; Montastruc JL; Gharib C; Geelen G; De Saint-Blanquat G; Tran MA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):770-7. PubMed ID: 1968975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.
    Cubeddu LX; Hoffmann IS; James MK; Niedzwiecki DM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):680-5. PubMed ID: 6887008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P levels in the rat forebrain after apomorphine and haloperidol treatment.
    Janicki P; Lypko A; Szczudlik A; Libich J
    Pol J Pharmacol Pharm; 1981; 33(5):499-502. PubMed ID: 6174959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia.
    Meltzer HY; Lee MA; Jayathilake K
    Neuropsychopharmacology; 2001 Mar; 24(3):278-90. PubMed ID: 11166518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons.
    Napier TC; Givens BS; Schulz DW; Bunney BS; Breese GR; Mailman RB
    J Pharmacol Exp Ther; 1986 Mar; 236(3):838-45. PubMed ID: 3512819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of VIP (vasoactive intestinal polypeptide)-like immunoreactivity in peripheral venous blood of dogs following injections of apomorphine and bromocriptine. Do dopaminergic agents induce gastric relaxation and hypotension by a release of endogenous VIP?
    Uvnäs-Moberg K; Goiny M; Posloncec B; Blomquist L
    Acta Physiol Scand; 1982 Jul; 115(3):373-5. PubMed ID: 7180533
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopaminergic and cholinergic influences on motor behavior in chickens.
    Sanberg PR
    J Comp Psychol; 1983 Mar; 97(1):59-68. PubMed ID: 6872506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.
    Delva NJ; Brooks DL; Franklin M; al-Said K; Hawken ER; Merali Z; Lawson JS; Ravindran AV
    J Psychiatry Neurosci; 2002 Nov; 27(6):429-37. PubMed ID: 12491576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of VIP-like immunoreactivity in response to dopamine agonists, insulin hypoglycemia and feeding in conscious dogs.
    Uvnäs-Moberg K; Goiny M; Blomquist LE; Elwin CE
    Peptides; 1984; 5(2):399-402. PubMed ID: 6147818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.